NEOGENOMICS INC — Director's Dealing 2014

Aug 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2014-04-15

Reporting Person: Johnson Kevin C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-15	Common Stock	A	3000	$3.05	Acquired	3000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	66667	Indirect
Common Stock	24000	Indirect

Footnotes

F1: On April 27, 2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Johnson remains a Director of the Company.

F2: On April 15, 2014 the Board of Directors approved and granted a restricted stock award of 3,000 shares of NeoGenomics common stock. The terms of the award call for 750 shares to vest on the last of the next 4 quarters starting on June 30, 2014 as long as Mr. Johnson remains a Director of the Company.